NACI issues recommendations for use in special populations and addresses other key issues including vaccine efficacy, co-administration with other vaccines, dosing, post-vaccination counselling.
WHO finds insufficient evidence that remdesivir improves survival or other outcomes in hospitalized patients with COVID-19, regardless of disease severity.
It often seems like children catch one cold after another all winter long. In fact, they can get as many as eight to 10 colds each year before they turn two years old.